Neorgana: Bringing Japanese Dezawa MUSE Cells™ to the Forefront of Regenerative Medicine in Mexico

The medical profession is living through a profound transformation. Its mission is no longer only to treat disease, but to regenerate life, restore vitality, and extend human potential. At the center of this movement in Latin America is Neorgana, a pioneering Mexican company recognized as one of the leading institutions working in close collaboration with MUSE Cell Innovations™ (MCI) in Japan and with Dr. Mari Dezawa, the scientist who discovered MUSE Cells™.

As an officially authorized center by MCI, Neorgana stands among a select group of clinics worldwide entrusted with the application of authentic Dezawa MUSE Cells™ and Dezawa MUSE Exosomes™. These groundbreaking biologics, developed in Japan, have shown remarkable potential in addressing conditions ranging from neurodegeneration to systemic inflammation, while also offering applications in longevity and human performance.

For the first time, this advanced Japanese science is available in Mexico, opening access to therapies previously reserved for elite research institutions abroad. With this collaboration, Neorgana is redefining what it means to heal and thrive—merging cutting-edge cellular science with clinical excellence to position Mexico at the vanguard of regenerative medicine.

Omar Novelo: The Visionary Behind Neorgana

At the helm of Neorgana stands Omar Novelo, CEO and cofounder alongside his wife, Tatiana Holder-Novelo, a recognized medical researcher. Together, they have shaped Neorgana into a transformative force in regenerative medicine—an institution dedicated to making cutting-edge science accessible not only in Mexico, but across Latin America.

For years, Novelo has worked tirelessly to forge international collaborations with laboratories, eminent scientists, and innovators. His mission has been clear: to ensure that world-class medical solutions reach the people of Mexico and Latin America, rather than remain confined to elite research centers abroad.

His vision for Neorgana is ambitious yet precise: to position the region as a global stronghold where cellular therapy, longevity science, and clinical excellence converge.

“Dezawa MUSE Cells™ mark the beginning of a new medical renaissance, fulfilling the original promise of stem cell therapy ” Novelo Says 

We are providing therapies today that transform the way humans recover , rejuvenate and extend their lifespan mantaining youthfull vitality 

Under his leadership, Neorgana has earned recognition as a technology leader and a trusted name within the international medical community. By prioritizing safety, authenticity, and measurable results, Novelo has not only advanced the reputation of Neorgana, but has also placed Mexico and Latin America at the forefront of the regenerative medicine revolution

Neorgana: Redefining Regenerative Medicine in Mexico and Latin America

Neorgana is not merely a health care provider; it represents a movement of vision—one that brings the world’s most advanced regenerative technologies into Mexico and throughout Latin America.

At the core of Neorgana’s therapies is the Dezawa MUSE Cell™, a groundbreaking Japanese discovery that marks the next step beyond conventional stem cell therapy. Unlike traditional Mesenchymal Stem Cells (MSCs), which primarily signal repair, MUSE Cells™ are stress-resistant, pluripotent, and uniquely capable of homing to damaged organs, where they regenerate tissue by transforming into organ-specific cells.

This breakthrough places Neorgana at the forefront of both global longevity science and advanced healing, bridging the gap between elite research and real-world clinical practice.

For this purpose, Neorgana.com serves as more than a corporate website: it is a digital gateway where patients, professionals, and collaborators can access the science, vision, and partnerships driving this revolution. It blends education, transparency, and accessibility, ensuring that regenerative medicine no longer remains confined to laboratories or research institutions, but becomes available to anyone determined to embrace the future of health.

The Breakthrough of Dezawa MUSE Cells™

The discovery of MUSE Cells™ (Multi-lineage-differentiating Stress-Enduring Cells) by Japanese scientist Professor Mari Dezawa in 2010 marked a turning point in regenerative medicine. Unlike conventional mesenchymal stem cells (MSCs), which have limited regenerative ability, MUSE Cells™ possess unique properties that redefine what cellular therapy can achieve.

So, what makes them revolutionary?

• Pluripotent Cells: MUSE Cells™ can transform into new neurons, liver, muscle, skin, and other specialized cells—actively replacing damaged tissue.
• Self-Homing Ability: They naturally migrate to injured organs and tissues, locating the exact site of damage.
• Stress Resilience: Unlike traditional MSCs, MUSE Cells™ survive hostile environments inside the body, ensuring greater effectiveness and survival  after administration.
• Superior Engraftment: Their ability to integrate into damaged tissue is significantly higher than conventional stem cells.
• A Safe Profile: MUSE Cells™ carry no tumor risk and, due to expression of HLA-G, often do not require immunosuppressants.
• Organ-Specific Applications: Early clinical studies suggest promising results in recovery from stroke, heart disease, autoimmune disorders, chronic wounds, liver injury, and neurodegenerative diseases

In this sense, Dezawa MUSE Cells™ represent a breakthrough at the intersection of health, antiaging , and recovery—unlocking possibilities once thought to belong to the future of medicine, now available today.

Mexico on the Global Map of Innovation

Thanks to Neorgana, Mexico is now at the forefront of a new medical renaissance. Patients no longer need to travel to Europe, Japan, or the United States to access the most advanced regenerative procedures—the future of medicine is available right here in Latin America.

Neorgana has transformed Mexico into a true hub of research and innovation. This milestone positions the country not only as a consumer of medical progress, but as a global leader in the new era of regenerative medicine.

It is a bold statement, but a true one: the future of health no longer resides in distant laboratories—it is available here and now.